IMVT - Immunovant  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMVT is currently covered by 14 analysts with an average price target of $35.47. This is a potential upside of $14.2 (66.76%) from yesterday's end of day stock price of $21.27.

Immunovant 's activity chart (see below) currently has 72 price targets and 101 ratings on display. The stock rating distribution of IMVT is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 60.16% with an average time for these price targets to be met of 180.65 days.

Highest price target for IMVT is $53, Lowest price target is $36, average price target is $35.47.

Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 10-Feb-2025. First documented stock forecast 07-Jan-2020.

Currently out of the existing stock ratings of IMVT, 52 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$51

$29.73 (139.77%)

$51

12 days ago
(10-Feb-2025)

11/19 (57.89%)

$31.48 (161.27%)

268

Buy

$44

$22.73 (106.86%)

$48

12 days ago
(10-Feb-2025)

3/7 (42.86%)

$24.48 (125.41%)

119

Buy

$45

$23.73 (111.57%)

$28

1 months 7 days ago
(15-Jan-2025)

1/2 (50%)

$20.6 (84.43%)

126

Buy

$45

$23.73 (111.57%)

$48

2 months 3 days ago
(19-Dec-2024)

4/8 (50%)

$19.34 (75.37%)

371

Buy

$36

$14.73 (69.25%)

$40

4 months 12 days ago
(10-Oct-2024)

2/3 (66.67%)

$6.07 (20.28%)

35

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IMVT (Immunovant ) average time for price targets to be met?

On average it took 180.65 days on average for the stock forecasts to be realized with a an average price target met ratio 60.16

Which analyst has the current highest performing score on IMVT (Immunovant ) with a proven track record?

GBOLA AMUSA

Which analyst has the most public recommendations on IMVT (Immunovant )?

Gbola Amusa works at CHARDAN CAPITAL and has 0 price targets and 7 ratings on IMVT

Which analyst is the currently most bullish on IMVT (Immunovant )?

Yasmeen Rahimi with highest potential upside - $35.73

Which analyst is the currently most reserved on IMVT (Immunovant )?

Tiago Fauth with lowest potential downside - -$14.27

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?